Chemed (NYSE:CHE) Downgraded by StockNews.com to Hold

StockNews.com lowered shares of Chemed (NYSE:CHE – Free Report) from a buy rating to a hold rating in a research note released on Friday morning. A number of other research analysts also recently commented on the company. Royal Bank of Canada increased their target price on Chemed from $604.00 to $712.00 and gave the company […]

Related Keywords

Canada ,Wellington ,New Zealand General ,New Zealand ,United States ,Spencers Lee ,Brianc Judkins , ,Chemed Corporation ,Impax Asset Management Group ,Royal Bank ,Wellington Management Group ,Securities Exchange Commission ,Jpmorgan Chase Co ,Kayne Anderson Rudnick Investment Management ,Free Report ,Trading Down ,Get Free Report ,Exchange Commission ,Anderson Rudnick Investment Management ,Management Group ,Asset Management Group ,Chemed Daily ,Schemed ,Nyse Che ,Oche ,Medical ,16359r10 ,Downgrade ,Stocknews Com ,